360 High-Risk Vulnerability Immunization Tool V2.0 vs Rapid7 Nexpose

360 High-Risk Vulnerability Immunization Tool V2.0

360 High-Risk Vulnerability Immunization Tool V2.0

Tool that immunizes Windows systems against critical vulnerabilities

Rapid7 Nexpose

Rapid7 Nexpose

On-premise vulnerability scanner with asset discovery and risk prioritization

Side-by-Side Comparison

Feature
360 High-Risk Vulnerability Immunization Tool V2.0
Rapid7 Nexpose
Pricing Model
Commercial
Commercial
Category
Vulnerability Assessment
Vulnerability Assessment
Verified Vendor
Deployment & Fit
Deployment Type
On-Premises
On-Premises
Company Size Fit
Startup, SMB, Mid-Market, Enterprise
SMB, Mid-Market, Enterprise
Company Information
Company
360 Security Group (Qihoo 360)
Rapid7
Headquarters
Beijing, Beijing, China
Boston, Massachusetts, United States
Founded, Size & Funding
Use Cases & Capabilities
Windows Security
Remote Desktop
CVE
Zero Day
Patch Management
System Security
NIST CSF 2.0 Coverage

Sign in to compare nist csf 2.0 coverage

Get detailed side-by-side nist csf 2.0 coverage comparison by signing in.

Core Features

Sign in to compare features

Get detailed side-by-side features comparison by signing in.

Integrations

Sign in to compare integrations

Get detailed side-by-side integrations comparison by signing in.

Community
Community Votes
0
0
Bookmarks
User Reviews

Sign in to view reviews

Read reviews from security professionals and share your experience.

Sign in to view reviews

Read reviews from security professionals and share your experience.

Need help choosing?

Explore more tools in this category or create a security stack with your selections.

Want to compare different tools?

Compare Other Tools

360 High-Risk Vulnerability Immunization Tool V2.0 vs Rapid7 Nexpose: Complete 2026 Comparison

Choosing between 360 High-Risk Vulnerability Immunization Tool V2.0 and Rapid7 Nexpose for your vulnerability assessment needs? This comprehensive comparison analyzes both tools across key dimensions including features, pricing, integrations, and user reviews to help you make an informed decision.

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities

Rapid7 Nexpose: On-premise vulnerability scanner with asset discovery and risk prioritization

Frequently Asked Questions

What is the difference between 360 High-Risk Vulnerability Immunization Tool V2.0 vs Rapid7 Nexpose?

**360 High-Risk Vulnerability Immunization Tool V2.0**: Tool that immunizes Windows systems against critical vulnerabilities. Built by 360 Security Group (Qihoo 360). headquartered in China. core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. **Rapid7 Nexpose**: On-premise vulnerability scanner with asset discovery and risk prioritization. Built by Rapid7. headquartered in United States. core capabilities include Real Risk Score with 1-1000 scale incorporating vulnerability age and exploit data, Adaptive Security for automatic detection and assessment of new devices, Policy assessment and benchmarking against CIS and NIST standards. Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

What features do 360 High-Risk Vulnerability Immunization Tool V2.0 vs Rapid7 Nexpose offer?

**360 High-Risk Vulnerability Immunization Tool V2.0** differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. **Rapid7 Nexpose** differentiates with Real Risk Score with 1-1000 scale incorporating vulnerability age and exploit data, Adaptive Security for automatic detection and assessment of new devices, Policy assessment and benchmarking against CIS and NIST standards.

Who makes 360 High-Risk Vulnerability Immunization Tool V2.0 vs Rapid7 Nexpose?

**360 High-Risk Vulnerability Immunization Tool V2.0** is developed by 360 Security Group (Qihoo 360). **Rapid7 Nexpose** is developed by Rapid7. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

Is 360 High-Risk Vulnerability Immunization Tool V2.0 a good alternative to Rapid7 Nexpose?

360 High-Risk Vulnerability Immunization Tool V2.0 and Rapid7 Nexpose serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.

Related Comparisons

Explore More Vulnerability Assessment Tools

Discover and compare all vulnerability assessment solutions in our comprehensive directory.

Browse Vulnerability Assessment

Looking for a different comparison? Explore our complete tool comparison directory.

Compare Other Tools